![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 04, 2021 5:39:21 PM
The only fraud that's going on here is when Amarex billed CytoDyn $80m"--REALLY??
Yes, REALLY. This PR is from Amarex - not CytoDyn. And this isn't fraudulent on Amarex???
Let's see the failed 13D gang of miscreants spin this one (they'll probably tell us it was written by NP who showed up at their office with a gun and forced them to release this PR). Why do the 13D gang of miscreants continue to lurk around in the dark and spin their webs of deceit? I bet one of the disgruntled 13D gang members, Anthony Caracciolo, can answer that question, but you'll have to find his Florida hideout to ask him the question. I hear Tampa is a good place to start the search.
https://www.amarexcro.com/news/amarex-sumits-biologics-license-cytodyn
"Amarex Submits a Biologics License Application (BLA) on Behalf of its Client, CytoDyn, for a Product to Treat HIV Patients
Germantown, MD, USA (April 28, 2020) – Amarex Clinical Research, LLC, an NSF International company, announces today that they submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the product leronlimab (PRO 140), on behalf of their client, CytoDyn. The application was finalized with the submission of the clinical and CMC (chemistry, manufacturing and controls) sections of the BLA. The drug will be administered as a combined therapy in the treatment of HIV.
Amarex was involved in preparation of this BLA, providing biostatistics, medical writing and regulatory services. Kazem Kazempour, Ph.D., Co-Founder, President and Chief Executive Officer of Amarex said, “We have worked with our client CytoDyn for a number of years on PRO 140, and we are pleased to see that, after much hard work and dedication, we are moving towards marketing approval. Our clinical trials have been successful thus far, with PRO 140, and we hope to have the same result for ongoing trials of this drug in other indications."
My comments are just my opinions and should NOT be taken as investment advice.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM